Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis - PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Non–small cell lung cancer (NSCLC) comprises approximately four fifths of all primary lung
carcinomas in the United States. A greater number of individuals will have succumbed to …

Patients presenting with early stage non-small cell lung cancer (NSCLC) are commonly
thought to have a favourableprognosis after resection. However, patients with pathological …

We performed a retrospective analysis of potential prognostic markers in 260 patients with
surgically resected stage I and II non–small-cell lung cancer (NSCLC) with a minimum 5 …

Non-small cell lung carcinoma (NSCLC) is a histologically heterogeneous collection of
tumours with variable clinical behaviour. Performance status, tumour stage and histological …

Among patients with resected non-small cell lung carcinoma, about 50% will present a tumor
recurrence. Thus, it would be of major importance to be able to predict and try to prevent …

Identification of prognostic factors is critical in optimizing treatment for patients with cancer.
The purpose of this work is to review the modern literature with regard to prognostic factors …

To evaluate the impact of non-small cell lung cancer (NSCLC) histological subtypes on
survival, we performed a retrospective multivariate analysis of survival in 361 patients with a …

PURPOSE This study investigated the frequency of the expression and prognostic
significance of a panel of immunocytochemical markers in resected non-small-cell lung …

Background: The outcome of treatment in non-small cell lung cancer (NSCLC) remains poor.
One of the reasons is that in many patients its biological behavior does not follow a definite …